Below are some of the key findings from the hemophilia A therapeutics market analysis:

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Get a FREE sample now!
Global hemophilia A therapeutics industry overview
The increased demand for prophylactic treatment for hemophilia A is one of the critical reasons that will drive the hemophilia A therapeutics market’s growth. This treatment minimizes the risk of developing inhibitors and prevents bleeding episodes. Prophylactic clotting factor regimen not only prevents hemarthrosis that is associated with hemophilia A but also avoids chronic microhemorrhage into joints. Many patients are using long-acting recombinant factor VIII therapies as prophylactic treatments.
The emergence of novel convenient approaches is gaining prominence in the market as they offer long-lasting therapeutic benefits from bleeding episodes. This will drive the hemophilia A therapeutics market to grow at a CAGR of almost 7% during the forecast period. AFSTYLA is one of the best examples of long-lasting therapy that is used to reduce the frequency of bleeding episodes in patients with hemophilia A.
Top hemophilia A therapeutics companies covered in this market research report
The hemophilia A therapeutics market is fairly fragmented. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this hemophilia A therapeutics industry analysis report will allow the clients to identify new growth opportunities and design innovative strategies to improve their share in the market.
The report offers a complete analysis of various companies including:
- Bayer
- CSL
- Novo Nordisk
- Pfizer
- Shire
Hemophilia A therapeutics market segmentation based on geographic regions
The Americas will contribute the highest market share throughout the forecast period. The new drug approvals of long-acting and curative therapies for hemophilia A is one of the primary reasons for the high growth of the hemophilia A therapeutics market in this region.
Hemophilia A therapeutics market segmentation based on product
- Recombinant therapies
- Plasma-derived therapies
- Hormonal therapies
The recombinant therapies segment will account for the highest market share in the hemophilia A therapeutics market as recombinant therapies that treat hemophilia A are safer than plasma-derived products.
Key highlights of the global hemophilia A therapeutics market for the forecast years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the hemophilia A therapeutics market during the next five years
- Precise estimation of the global hemophilia A therapeutics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the hemophilia A therapeutics industry across various geographies such as the Americas, APAC, and EMEA
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details on factors that will challenge the growth of multivariable transmitters companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: PIPELINE ANALYSIS
PART 05: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- The threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Recombinant therapies - Market size and forecast 2018-2023
- Plasma-derived therapies - Market size and forecast 2018-2023
- Hormonal therapies - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY TYPE
- On-demand treatment
- Prophylactic treatment
- Inhibitor treatment
PART 10: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Americas - Market size and forecast 2018-2023
- EMEA - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Bayer
- CSL
- Novo Nordisk
- Pfizer
- Shire
PART 15: APPENDIX
- Research methodology
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape